retatrutide triple agonist glp-1 gip glucagon phase 2 results Efficacy and safety of retatrutide, a GIP, GLP-1, and receptor agonist, in people with type diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, 3 What Is Retatrutide? The Triple

One possible side effect of GLP-1s is constipation, and eating foods high in fiber can help

Lower cases were reported in the thyroid, bladder, colorectal, and pancreas compared to a treatment period of 104 weeks with 0.5 mg of semaglutide, which yielded 155 cases of neoplasm

These hormones are released after a meal to help regulate blood sugar and signal fullness by telling the pancreas to release more insulin and the liver to make less sugar

Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, et al

Additionally, the FDA's adverse event reporting system received 489 reports of patients experiencing mental health issues, including depression and anxiety, while on semaglutide (Ozempic's active ingredient)

It is not approved for human consumption, diagnostic use, therapeutic application, or veterinary use